Diabetes and fatty liver study with a combined medicine
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests a combination of two diabetes medicines to see how well they improve blood sugar control, fat metabolism, and the health of your pancreas in people who have both type 2 diabetes and fatty liver disease. The goal is to find treatments that help both conditions at the same time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with type 2 diabetes and also have fatty liver disease.
- Your A1c (average blood sugar) is between 6.5% and 9.5%.
- Your body mass index (BMI) is between 19 and 35.
- You have not taken any diabetes pills or insulin in the last 6 months.
- You do not have severe heart, kidney, liver, or brain problems, cancer, or other serious conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how often people with type 2 diabetes also have fatty liver disease, and whether a new combination medication (dapagliflozin and pioglitazone) can help manage both conditions.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This trial tests how combining a ketone supplement with certain diabetes medicines affects blood sugar and ketone levels. It may help adults with type 2 diabetes who are not on insulin or certain other drugs.
This trial is testing different combinations of diabetes medicines to see which one helps keep your blood sugar more steady throughout the day. It's for people with type 2 diabetes who are already taking metformin and an SGLT-2 inhibitor but still have high blood sugar.
This study tests a medicine commonly used for diabetes to see if it can help people with fatty liver disease. The medicine may reduce fat in the liver and improve liver health.
This study tests a combination of three diabetes medicines (empagliflozin, linagliptin, and metformin) to see if it helps control blood sugar in people with type 2 diabetes. It may be an option if your current treatment isn't working well enough.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.